ACADIA Pharmaceuticals, Inc.

NASDAQ: ACAD
$51.24
-$0.33 (-0.6%)
Closing price May 22, 2020
Thursday's top analyst upgrades and downgrades included Bed Bath & Beyond, Ciena, DocuSign, eHealth, Faceboook, Netflix, PNC Financial Services, Square, Tilray, Twitter and Zoom Video Communications.
Jon C. Ogg
Monday's top analyst upgrades, downgrades and initiations included Adobe, Amgen, Bank of America, Broadcom, CME, Goldman Sachs, Micron Technology, PepsiCo, UnitedHealth, Urban Outfitters and Vertex...
Jon C. Ogg
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Chris Lange
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of December.
Chris Lange
Acadia shares made a handy gain on Monday after the firm announced positive results from an eight-week Phase 2 study evaluating pimavanserin as a therapy for Parkinson’s disease patients with...
Chris Lange
The top analyst upgrades, downgrades and initiations seen on Friday included Acadia Pharmaceuticals, Broadcom, CBOE Global Markets, Etsy, Gap, General Electric, Home Depot, Lowe's Companies, Oracle...
Jon C. Ogg
Acadia Pharmaceuticals shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint.
Chris Lange
Acadia Pharmaceuticals shares dropped on Tuesday after the firm announced results from its late-stage study for the treatment of adult schizophrenia patients.
Chris Lange
Acadia Pharmaceuticals shares dipped on Wednesday despite announcing positive top-line results from its Clarity mid-stage study in major depressive disorder (MDD).
Chris Lange
Acadia Pharmaceuticals shares popped after the company announced that the FDA completed a postmarketing review and issued a clear statement reaffirming the positive benefit-risk profile of Nuplazid...
Chris Lange
The top analyst upgrades, downgrades and initiations seen on Friday include AMD, Alcoa, AT&T, Darden Restaurants, Micron Technology, New Age Beverages, Nike, Novavax, Pier 1 Imports and Under...
Jon C. Ogg
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
Chris Lange
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.
Jon C. Ogg
Ultra Petroleum, Coty, e.l.f. Beauty, and Acadia Pharmaceuticals all posted new 52-week lows Thursday.
Paul Ausick
24/7 Wall St. tracked six companies that saw three or more analyst downgrades or price target cuts on Thursday, August 9, 2018.
Jon C. Ogg